About Aeris Therapeutics
Aeris Therapeutics is a Healthcare company based in Woburn (United States) founded in 2000, and was acquired by Pulmonx in January 2015. Products for treating emphysema and lung diseases are developed. The company was acqui-hired. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its competitors include Pulmonx, Spiration and Uptake Medical; 3 of its 3 listed competitors have raised funding.
Company details
Aeris Therapeutics was founded in 2000 and is based in Woburn, United States. Focus is placed on medical devices within the pulmonology sector. The AeriSeal System is provided to decrease lung volume and enhance function for individuals with severe emphysema. Damaged lung regions are addressed through bronchoscope-based procedures. Operations center on advancing treatments for emphysema and related respiratory conditions.
- Headquarters Woburn, United States
- Stage Acquired
- SectorsHealthcare
- Website aerist.com
- Social LinkedIn Facebook
- Acquired by Pulmonx (Jan 2015)
Funding Insights of Aeris Therapeutics
- Total Rounds 3
- Last Round Grant — $391,775
- First Round $783,550
(Sep 2004)
- Investors Count 1
All 3 funding rounds of Aeris Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Aeris Therapeutics
Aeris Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Pulmonx and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Developer of smart devices for treating pulmonary diseases | 1998 | pulmonx.com | Redwood City, United States |
Investor details for Aeris Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aeris Therapeutics
4 dated milestones of Aeris Therapeutics across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Aeris Therapeutics is founded.
- Funding First funding round of $784K.
- Funding Latest funding round, Grant, of $392K.
- Exit Acquired by Pulmonx.
Competitors of Aeris Therapeutics
Aeris Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Pulmonx, Spiration and Uptake Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pulmonx.com | 1998 | Redwood, United States | $280.91M | 198 | Developer of smart devices for treating pulmonary diseases | |
| spiration.com | 1999 | Redmond, United States | $73.9M | 74 | IntraBronchial Valve to treat lung disease | |
| uptakemedical.com | 2005 | Tustin, United States | $71.68M | Targeted vapor therapy is developed for endoscopic lung volume reduction. |
Detailed competitors of Aeris Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pulmonology
3 companies that operate in the same segment as Aeris Therapeutics (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aeris Therapeutics
Aeris Therapeutics was founded in 2000 and raised its 1st funding round 4 years after it was founded.
Aeris Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Aeris Therapeutics was founded in 2000 and is based in Woburn, United States. Focus is placed on medical devices within the pulmonology sector. The AeriSeal System is provided to decrease lung volume and enhance function for individuals with severe emphysema. Damaged lung regions are addressed through bronchoscope-based procedures. Operations center on advancing treatments for emphysema and related respiratory conditions.
Aeris Therapeutics's top competitors include Pulmonx, Spiration and Uptake Medical.
Yes. Aeris Therapeutics was acquired by Pulmonx in January 2015.